2020
DOI: 10.1016/j.bbamcr.2020.118728
|View full text |Cite
|
Sign up to set email alerts
|

Hsp90 facilitates acquired drug resistance of tumor cells through cholesterol modulation however independent of tumor progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(15 citation statements)
references
References 65 publications
3
11
0
Order By: Relevance
“…In agreement with our earlier findings, we observed enhanced drug efflux activity in response to 17AAG treatment (Figure 1C). Further, we also demonstrated that P‐glycoprotein (P‐gp) majorly contributes to the acquired drug resistance, therefore, in the present study, the drug efflux activity that we mentioned is pertinent to P‐gp activity 23 …”
Section: Resultssupporting
confidence: 60%
See 4 more Smart Citations
“…In agreement with our earlier findings, we observed enhanced drug efflux activity in response to 17AAG treatment (Figure 1C). Further, we also demonstrated that P‐glycoprotein (P‐gp) majorly contributes to the acquired drug resistance, therefore, in the present study, the drug efflux activity that we mentioned is pertinent to P‐gp activity 23 …”
Section: Resultssupporting
confidence: 60%
“…Our earlier in vitro findings with drug-resistant cells have indicated that inhibiting metastasis will not interfere with the drug efflux activity. 23 MMPs to interfere with tumor metastasis has emerged. However, the current MMP inhibitors aim the conserved catalytic site, thus lacks the individual MMP specificity and selectivity.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations